Filing Summary
Registrant: Brilliant Acquisition Corporation, a British Virgin Islands special purpose acquisition company. The request identifies T3 Defense Inc., but the filing names Brilliant as the registrant.
Report date: October 20, 2023; filed October 23, 2023. This Form 8-K reports a sponsor financing and an extension of the deadline to complete an initial business combination.
Business Context and Reporting Period
Brilliant is pursuing a proposed business combination with Nukkleus, Inc. through a merger subsidiary. The transaction remains subject to shareholder approvals, regulatory approvals, satisfaction of closing conditions, and other requirements described in the Form S-4 and related proxy statement/prospectus.
Financial Position and Key Metrics
- Promissory note: On October 20, 2023, Brilliant issued its sponsor, Nisun Investment Holding Limited, an unsecured promissory note with principal of $32,300.
- Interest and maturity: The note bears no interest and matures upon closing of the initial business combination.
- Repayment: If no business combination is completed, repayment will be made only from amounts remaining outside the trust account, if any.
- Use of proceeds: The proceeds were deposited into the trust account in connection with extending the business-combination deadline.
- Revenue, profit, cash flow, margins, debt, and liquidity: The filing does not provide a clear value for these operating or financial metrics. It discloses only the $32,300 sponsor note and related trust-account deposit.
Material Changes Versus the Prior Comparable Period
- Brilliant extended the period available to complete its initial business combination by one month, from the prior deadline to November 23, 2023.
- The company incurred a new $32,300 unsecured, non-interest-bearing obligation to its sponsor.
- The filing does not provide comparative financial statements or quantify other changes versus the prior period.
Guidance, Outlook, Risks, and Unusual Items
- The principal outlook item is completion of the proposed Brilliant-Nukkleus business combination by the applicable deadline.
- Key risks include failure to complete the transaction on time, failure to obtain a further extension, shareholder redemptions reducing the trust account below the required minimum, failure to obtain shareholder or regulatory approvals, litigation, Nasdaq listing risks, and volatility in the securities of Brilliant and Nukkleus.
- If the business combination is not completed, the sponsor note is payable only from funds outside the trust account, if any; the filing does not state the amount available for repayment.
- The proposed transaction and related disclosures are subject to the risks and uncertainties described in the Form S-4, proxy statement/prospectus, and other SEC filings.
- The Item 7.01 press release is furnished rather than filed for purposes of Section 18 of the Exchange Act, except as otherwise expressly incorporated.
Investor Verification Checklist
- Verify the current status of the Brilliant-Nukkleus merger, including Form S-4 effectiveness, shareholder votes, regulatory approvals, and remaining closing conditions.
- Confirm the applicable business-combination deadline and whether any subsequent extension was obtained after November 23, 2023.
- Review the trust-account balance, redemption activity, and minimum trust-account condition.
- Read the full October 20, 2023 promissory note and confirm its repayment terms and any subsequent amendments.
- Review the Form S-4, proxy statement/prospectus, and current SEC filings for transaction risks, dilution, capital structure, and financial information not included in this Form 8-K.